Recent Company News

• 09:36 PM ET Jul 31, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:36 AM ET Jul 30, 2026
  

  Oral Oncology Journal accepts for publication new CEL-SCI Multikine Ph3 data demonstrating overall survival benefit in underserved head and neck cancer patients ($1.14, 0.00)

• 05:20 PM ET Jul 29, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 11:03 AM ET Jul 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q2 Earnings Guidance ($34.39, +2.72)

• 11:03 AM ET Jul 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q2 Earnings Themes ($34.42, +2.75)

• 11:03 AM ET Jul 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q2 Earnings Q&A ($34.43, +2.76)

• 09:27 AM ET Jul 29, 2026
  

  Alvotech announces successful closure of FDA inspection of manufacturing facility ($3.10, 0.00)

• 09:17 AM ET Jul 29, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:44 AM ET Jul 29, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:17 AM ET Jul 29, 2026
  

  StreetAccount Summary - US Pre-market trading